BioData, producer of Labguru, the web-based research and lab management system, has announced that the Innovative Medicines unit of global pharmaceutical business, AstraZeneca, has adopted the Labguru platform for the global management of biological reagents used in pre-clinical research.
Scientists will use the Labguru platform across multiple AstraZeneca sites in North America and Europe, replacing and consolidating several legacy systems spanning several scientific disciplines. Its modular web-based system offers an easy means of tracking projects, protocols, biological collections and materials, as well as streamlining collaboration between members of the lab and between institutions.
A Digital Science portfolio company, BioData's services benefit individual researchers at the bench, and also enhance collaboration and knowledge management across research teams and institutions. Labguru's order management, equipment sharing, and storage mapping features reduce costs and streamline administrative tasks.
